Both the serum level and immunohistochemical expression of AFP can be used to indicate the poor prognosis for gastric adenocarcinoma, while the SALL4 immunohistochemistry can also be an indicator of adverse prognosis for such cancer (Wang et al. 2021a). Here, SALL4 is linked to cancer.